Rep. Thomas Massie (R-KY) pointed out after Congress voted Wednesday to give another $40 billion to Ukraine that the U.S. will have spent more on Ukraine in six months than it did on all roads and bridges in the U.S. during the year, while other lawmakers pointed out that the U.S. is in the middle of a baby formula shortage that is becoming a crisis for parents.
Massie and 56 other Republicans voted against the “rushed” Ukraine aid package and pointed out that Democrats were putting America “last” in their eagerness to give the aid.
Counting last night’s rushed vote, Congress has now spent more money on Ukraine in six months than we spend on all US roads and bridges in a year.
… something to think about the next time you are stuck in traffic or replacing a bent rim.
— Thomas Massie (@RepThomasMassie) May 11, 2022
“Something to think about the next time you are stuck in traffic or replacing a bent rim,” Massie said.
Baby formula shortage
Massie also said on Tuesday before the vote that “Biden is more concerned with sending billions of $ to Ukraine than he is about baby formula shortages here in the United States.”
Rep. Jim Jordan (R-OH) agreed, tweeting, “More money for Ukraine while baby formula is out of stock for Americans? Voted No.”
Baby formula by popular brands is out of stock in at least 40% of stores nationwide even as births tick up and fewer moms are breastfeeding.
Changing to a different baby formula suddenly may cause gastrointestinal upset in babies, and some need specific formula brands because of allergies and sensitivities.
Republicans want action
Republicans on the House Energy and Commerce Committee led a letter with 106 GOP lawmakers to the Food and Drug Administration and the Biden administration asking them to directly address the shortage before it becomes a “life or death” crisis for babies, which need to be on the formula or breastfed for the first year of life.
Formula production was stopped at a large plant in Michigan when traces of a harmful bacteria were found and several infants were sickened by the same bacteria.
In addition, supply chain issues during the pandemic have affected formula, which saw an increase in demand early in the pandemic with a drop-off in 2021 as parents used their pandemic stockpiles. The current increase in demand caught makers by surprise, and it will take some time to increase production again.
“This is an urgent issue that the FDA, as you all know, and the White House is working 24/7 to address,” Deputy Press Secretary Karine Jean-Pierre told reporters, without giving any specifics on the efforts.